Top Markets
#1 Wrapped One Wrapped One +14,737.38%
#2 Wrapped STX (Velar) Wrapped STX (Velar) +2,972.21%
#3 Black Phoenix Black Phoenix +336.03%
#4 aPriori aPriori +129.63%
#5 Bedrock Bedrock +71.69%
#6 Cysic Cysic +50.00%
#7 Prom Prom +41.40%
#8 Playnance Playnance +35.14%
#9 COTI COTI +31.27%
#10 Bitway Bitway +27.79%
Coin of the day
Wrapped One Wrapped One
Configuración
Idioma
ESPAñOL
Moneda
USD
Tema
Allena Pharmaceuticals, Inc. Allena Pharmaceuticals, Inc.

Allena Pharmaceuticals, Inc.

ALNAQ
Clasificación en acciones #42825
Operating as a biopharmaceutical firm, Allena Pharmaceuticals, Inc. focuses on... Operating as a biopharmaceutical firm, Allena Pharmaceuticals, Inc. focuses on unearthing, developing, and marketing oral enzyme therapies. These treatments are devised to assist patients in the United States afflicted by uncommon and serious metabolic as well as renal conditions. Central to its pipeline is ALLN-346, an innovative enzyme designed to degrade urate, targeting hyperuricemia and gout in individuals with advanced chronic kidney disease. The company, which commenced operations in 2011 and has its main office in Newton, Massachusetts, made headlines on September 2, 2022, by seeking voluntary reorganization under Chapter 11 in the U.S. Bankruptcy Court for the District of Delaware.
Precio por acción
$0.000001
Última sincronización: 2023-12-13
Capitalización bursátil
$23.51
Cambio (1 día)
0.00%
Cambio (1 año)
0.00%
País
US
Comercio Allena Pharmaceuticals, Inc. (ALNAQ)

Categoría

Healthcare
Historial del precio de la acción de Allena Pharmaceuticals, Inc. (ALNAQ)
Precio más alto de cierre: $0.00 el 2023-12-01

Precio más bajo de cierre: $12.31 el 2017-11-01
Historial del precio de la acción de Allena Pharmaceuticals, Inc. desde 2017 hasta 2026
Desempeño anual del precio de la acción
Año Rendimiento
2023 -99.48%
2022 -98.68%
2021 -49.81%
2020 -41.78%
2019 -68.12%
2018 -43.00%
2017 0.00%
Precio de la acción de empresas similares o competidoras
Empresa Precio de la acción Cambio 1a% País
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $527.87 36.13%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $873.57 37.02%
NL
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 $736.38 8.73%
CH
UCB S.A. UCB S.A.
UCB S.A.
UCB.BR
 $263.09 20.45%
BE
Samsung Biologics Co.,Ltd. Samsung Biologics Co.,Ltd.
Samsung Biologics Co.,Ltd.
207940.KS
 $1.07K -5.56%
KR